Skip to main content

Advertisement

SpringerLink
Log in

Breast Cancer Disparities Related to Young Age at Diagnosis

  • Breast Cancer Disparities (LA Newman, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Despite being uncommon, breast cancer at a young age correlates with worse outcomes. Several aspects of a breast cancer diagnosis may affect young and older patients differently, including biology, genetic predisposition, fertility concerns, and psychosocial outcomes. Understanding these differences is critical to providing tailored, high-quality care to young patients.

Recent Findings

Young women with breast cancer are less likely to have early stage at presentation and more likely to have tumors with aggressive characteristics. Genetic mutations predisposing to breast cancer are more common. Due to their life stage, young women face concerns regarding fertility and pregnancy and are at higher risk for psychosocial distress.

Summary

Recent clinical trials in the adjuvant setting have provided insight on the optimal treatment for young patients. Multiple other studies have outlined the psychosocial impact of breast cancer in young patients, helping to understand their unique challenges. However, there is still need for further research, including around interventions, to address clinical and social concerns specific to young patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. American Cancer Society. Breast cancer facts & figures 2019–2020.

  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654.

    Article  Google Scholar 

  3. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324–30. https://doi.org/10.1200/JCO.2007.14.2471.

    Article  Google Scholar 

  4. Giaquinto AN, Miller KD, Tossas KY, Winn RA, Jemal A, Siegel RL. Cancer statistics for African American/Black people 2022. CA Cancer J Clin. 2022. https://doi.org/10.3322/caac.21718.

    Article  Google Scholar 

  5. Williams DR, Mohammed SA, Shields AE. Understanding and effectively addressing breast cancer in African American women: unpacking the social context. Cancer. 2016;122(14):2138–49. https://doi.org/10.1002/cncr.29935.

    Article  Google Scholar 

  6. Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, et al. Prospective observational study of breast cancer treatment outcomes for UK women aged 18–40 years at diagnosis: the POSH study. J Natl Cancer Inst. 2013;105(13):978–88. https://doi.org/10.1093/jnci/djt134.

    Article  CAS  Google Scholar 

  7. Zabicki K, Colbert JA, Dominguez FJ, Gadd MA, Hughes KS, Jones JL, et al. Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol. 2006;13(8):1072–7. https://doi.org/10.1245/ASO.2006.03.055.

    Article  Google Scholar 

  8. Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012;17(6):775–82. https://doi.org/10.1634/theoncologist.2011-0469.

    Article  Google Scholar 

  9. • Jain U, Jain B, Fayanju OM, Chino F, Dee EC. Disparities in timely treatment among young women with breast cancer. Am J Surg. 2022;S0002-9610(22)00020-4. https://doi.org/10.1016/j.amjsurg.2022.01.019. This study sought to assess sociodemographic disparities in delay of surgery among young women with breast cancer, using the National Cancer Database. The authors found that treatment delays were more frequent in Black women than in white women, highlighting racial disparities in access to care.

  10. • Guzmán-Arocho YD, Rosenberg SM, Garber JE, Vardeh H, Poorvu PD, Ruddy KJ, et al. Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. Br J Cancer. 2022;126(2):302–309. https://doi.org/10.1038/s41416-021-01597-2. This study investigated the clinical and pathological features of breast cancer in young women in a prospective cohort. The study also evaluated the association between BRCA1/BRCA2 mutations and surrogate molecular phenotypes, providing insight into the distinct features of breast cancer in young women.

  11. Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3(9):1190. https://doi.org/10.1001/jamaoncol.2017.0424.

    Article  Google Scholar 

  12. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic. https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf (Accessed on 22 Feb 2022).

  13. Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111–21. https://doi.org/10.1056/NEJMoa1804710.

    Article  CAS  Google Scholar 

  14. •• Piccart M, van 't Veer LJ, Poncet C, Lopes Cardozo JMN, Delaloge S, Pierga JY, et al. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. Lancet Oncol. 2021;22(4):476–488. https://doi.org/10.1016/S1470-2045(21)00007-3. The MINDACT trial was a large prospective study evaluating a gene-expression assay to estimate the benefit from the addition of adjuvant chemotherapy to endocrine therapy in patients with hormone receptor–positive, HER2-negative breast cancer. In this exploratory analysis, the authors reported on the effect of age on the benefit from chemotherapy.

  15. •• Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021 16;385(25):2336–2347. https://doi.org/10.1056/NEJMoa2108873. In this large prospective trial, women with hormone receptor–positive, HER2-negative breast cancer and 1–3 positive lymph nodes were randomized to receive endocrine therapy alone or endocrine therapy and chemotherapy. The results showed that premenopausal women who received chemotherapy had better disease outcomes, whereas postmenopausal women did not benefit from the addition of chemotherapy.

  16. Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med. 2018;379(2):122–37. https://doi.org/10.1056/NEJMoa1803164.

    Article  CAS  Google Scholar 

  17. Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, et al. Treatment efficacy, adherence, and quality of life among women younger than 35 years in the international breast cancer study group TEXT and SOFT adjuvant endocrine therapy Trials. J Clin Oncol. 2017;35(27):3113–22. https://doi.org/10.1200/JCO.2016.72.0946.

    Article  CAS  Google Scholar 

  18. Guo F, Kuo YF, Shih YCT, Giordano SH, Berenson AB. Trends in breast cancer mortality by stage at diagnosis among young women in the United States. Cancer. 2018;124(17):3500–9. https://doi.org/10.1002/cncr.31638.

    Article  Google Scholar 

  19. Kim HJ, Kim S, Freedman RA, Partridge AH. The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype a U.S. SEER database analysis. Breast. 2022;61:77–83. https://doi.org/10.1016/j.breast.2021.12.006.

    Article  Google Scholar 

  20. Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol. 2016;34(27):3308–14. https://doi.org/10.1200/JCO.2015.65.8013.

    Article  Google Scholar 

  21. Frank S, Carton M, Dubot C, Campone M, Pistilli B, Dalenc F, et al. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast. 2020;52:50–7. https://doi.org/10.1016/j.breast.2020.04.009.

    Article  Google Scholar 

  22. Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014;32(11):1151–6. https://doi.org/10.1200/JCO.2013.52.8877.

    Article  Google Scholar 

  23. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001. https://doi.org/10.1200/JCO.2018.78.1914.

    Article  Google Scholar 

  24. •• Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, et al. Pregnancy after breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2021;39(29):3293–3305. https://doi.org/10.1200/JCO.21.00535. This meta-analysis and systematic review sought to provide evidence on the impact of pregnancy after breast cancer in terms of reproductive outcomes and maternal safety. The results of disease outcomes provided evidence on the safety of pregnancy after breast cancer diagnosis.

  25. Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G, et al. Long-term safety of pregnancy following breast cancer according to estrogen receptor status. J Natl Cancer Inst. 2018;110(4):426–9. https://doi.org/10.1093/jnci/djx206.

    Article  Google Scholar 

  26. Lambertini M, Horicks F, Del Mastro L, Partridge AH, Demeestere I. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: from biological evidence to clinical application. Cancer Treat Rev. 2019;72:65–77. https://doi.org/10.1016/j.ctrv.2018.11.006.

    Article  CAS  Google Scholar 

  27. Pregnancy outcome and safety of interrupting therapy for women with endocrine responsive breast cancer (POSITIVE). ClinicalTrials.gov identifier: NCT02308085.

  28. Henry M, Huang LN, Sproule BJ, Cardonick EH. The psychological impact of a cancer diagnosed during pregnancy: determinants of long-term distress. Psychooncology. 2012;21(4):444–50. https://doi.org/10.1002/pon.1926.

    Article  Google Scholar 

  29. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(5):386–405. https://doi.org/10.1093/jnci/djr541.

    Article  Google Scholar 

  30. Rosenberg SM, Partridge AH. Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013;5(Suppl 1):S55-61. https://doi.org/10.3978/j.issn.2072-1439.2013.06.20.

    Article  Google Scholar 

  31. Ljungman L, Ahlgren J, Petersson LM, Flynn KE, Weinfurt K, Gorman JR, et al. Sexual dysfunction and reproductive concerns in young women with breast cancer: type, prevalence, and predictors of problems. Psychooncology. 2018;27(12):2770–7. https://doi.org/10.1002/pon.4886.

    Article  Google Scholar 

  32. Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120–8. https://doi.org/10.1200/JCO.2009.25.9655.

    Article  Google Scholar 

  33. Llarena NC, Estevez SL, Tucker SL, Jeruss JS. Impact of fertility concerns on tamoxifen initiation and persistence. J Natl Cancer Inst. 2015;107(10):202. https://doi.org/10.1093/jnci/djv202.

    Article  Google Scholar 

  34. Tangka FKL, Subramanian S, Jones M, Edwards P, Flanigan T, Kaganova Y, et al. Insurance coverage, employment status, and financial well-being of young women diagnosed with breast cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(3):616–24. https://doi.org/10.1158/1055-9965.EPI-19-0352.

    Article  Google Scholar 

  35. Ketterl TG, Syrjala KL, Casillas J, Jacobs LA, Palmer SC, McCabe MS, et al. Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors. Cancer. 2019;125(11):1908–17. https://doi.org/10.1002/cncr.31985.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Weill Cornell Medicine, New York, NY, USA

    Leticia Varella & Shoshana Rosenberg

Authors
  1. Leticia Varella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shoshana Rosenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leticia Varella.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Breast Cancer Disparities.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varella, L., Rosenberg, S. Breast Cancer Disparities Related to Young Age at Diagnosis. Curr Breast Cancer Rep 14, 174–179 (2022). https://doi.org/10.1007/s12609-022-00459-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-022-00459-x

Keywords

Search

Navigation